Deviation Reporting for Human Cells, Tissues, and Cellular and Tissue-Based Products Regulated Solely Under Section 361 of the Public Health Service Act and 21 CFR Part 1271: Guidance for Industry Leave a Comment / By florent.maestracci / 7 February 2023 7 February 2023 https://www.fda.gov/media/107703/download